Stock listing
Munich:S7C StenoCare A/S Aktie
German listing (Munich) of StenoCare A/S · home listing Copenhagen:STENO
Follow StenoCare A/S into a list and get an email when it puts out news.
Home listing price · OMXCOP:STENO
0.59 DKK -0.01 (-1.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXCOP:STENO
- Day range
- 0.532 – 0.624 DKKNov 20, 2026
- Volume
- 94,302 sharesNov 20, 2026
- Market cap
- 25.49M DKKAt the close on Nov 20, 2026 · price × 43.20M shares outstanding
- 52-week range
- 0.50 – 1.94 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 69,089 DKKMedian day 66,724 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Copenhagen:STENO · Home | 0.59 DKK | -0.01 (-1.7%) | 94,302 | 0.56 | 0.624 | 0.532 | 0.60 | Close on Nov 20, 2026 |
| Frankfurt:S7C | €0.069 EUR | -0.002 (-3.3%) | — | €0.073 | €0.073 | €0.069 | €0.072 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:STENO · DKK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.59 | -0.01 | -1.7% | 0.56 | 0.624 | 0.532 | 94,302 | |
| 0.60 | -0.038 | -6.0% | 0.62 | 0.638 | 0.50 | 183,845 | |
| 0.638 | -0.012 | -1.8% | 0.652 | 0.658 | 0.62 | 16,770 | |
| 0.65 | -0.022 | -3.3% | 0.668 | 0.67 | 0.622 | 55,440 | |
| 0.672 | +0.014 | +2.1% | 0.632 | 0.672 | 0.63 | 114,033 | |
| 0.658 | -0.012 | -1.8% | 0.67 | 0.684 | 0.626 | 70,454 | |
| 0.67 | -0.016 | -2.3% | 0.644 | 0.686 | 0.644 | 85,005 | |
| 0.686 | +0.012 | +1.8% | 0.662 | 0.686 | 0.654 | 100,733 | |
| 0.674 | -0.03 | -4.3% | 0.61 | 0.688 | 0.61 | 26,486 | |
| 0.704 | -0.02 | -2.8% | 0.732 | 0.732 | 0.57 | 261,458 | |
| 0.724 | +0.006 | +0.8% | 0.71 | 0.734 | 0.696 | 44,608 | |
| 0.718 | +0.008 | +1.1% | 0.71 | 0.746 | 0.702 | 51,437 | |
| 0.71 | +0.03 | +4.4% | 0.67 | 0.72 | 0.67 | 18,642 | |
| 0.68 | -0.004 | -0.6% | 0.684 | 0.698 | 0.68 | 43,878 | |
| 0.684 | -0.006 | -0.9% | 0.682 | 0.71 | 0.666 | 197,918 | |
| 0.69 | -0.01 | -1.4% | 0.686 | 0.69 | 0.66 | 19,916 | |
| 0.70 | +0.01 | +1.4% | 0.692 | 0.70 | 0.686 | 5,567 | |
| 0.69 | -0.008 | -1.1% | 0.652 | 0.70 | 0.652 | 37,924 | |
| 0.698 | +0.032 | +4.8% | 0.676 | 0.70 | 0.628 | 83,070 | |
| 0.666 | -0.01 | -1.5% | 0.672 | 0.676 | 0.626 | 114,621 | |
| 0.676 | +0.07 | +11.6% | 0.608 | 0.698 | 0.608 | 87,900 | |
| 0.606 | -0.022 | -3.5% | 0.60 | 0.646 | 0.582 | 63,160 | |
| 0.628 | +0.01 | +1.6% | 0.624 | 0.648 | 0.62 | 84,950 | |
| 0.618 | -0.02 | -3.1% | 0.602 | 0.658 | 0.584 | 99,901 | |
| 0.638 | -0.018 | -2.7% | 0.612 | 0.664 | 0.602 | 100,402 | |
| 0.656 | -0.026 | -3.8% | 0.684 | 0.70 | 0.57 | 259,095 | |
| 0.682 | -0.044 | -6.1% | 0.726 | 0.726 | 0.68 | 187,519 | |
| 0.726 | -0.054 | -6.9% | 0.78 | 0.78 | 0.706 | 48,627 | |
| 0.78 | +0.046 | +6.3% | 0.734 | 0.78 | 0.704 | 56,788 | |
| 0.734 | -0.038 | -4.9% | 0.81 | 0.81 | 0.702 | 113,607 | |
| 0.772 | +0.072 | +10.3% | 0.70 | 0.844 | 0.70 | 130,140 | |
| 0.70 | -0.148 | -17.5% | 0.822 | 0.822 | 0.656 | 410,366 | |
| 0.848 | -0.022 | -2.5% | 0.848 | 0.85 | 0.80 | 117,447 | |
| 0.87 | -0.01 | -1.1% | 0.862 | 0.882 | 0.842 | 62,471 | |
| 0.88 | -0.014 | -1.6% | 0.902 | 0.902 | 0.88 | 34,852 | |
| 0.894 | -0.03 | -3.2% | 0.89 | 0.922 | 0.89 | 47,787 | |
| 0.924 | -0.014 | -1.5% | 0.93 | 0.94 | 0.892 | 14,956 | |
| 0.938 | +0.05 | +5.6% | 0.888 | 0.946 | 0.888 | 8,981 | |
| 0.888 | -0.042 | -4.5% | 0.886 | 0.948 | 0.884 | 33,515 | |
| 0.93 | -0.01 | -1.1% | 0.942 | 0.946 | 0.894 | 22,291 | |
| 0.94 | +0.082 | +9.6% | 0.88 | 0.94 | 0.88 | 111,270 | |
| 0.858 | -0.03 | -3.4% | 0.884 | 0.884 | 0.852 | 32,187 | |
| 0.888 | -0.042 | -4.5% | 0.884 | 0.928 | 0.85 | 20,736 | |
| 0.93 | +0.01 | +1.1% | 0.89 | 0.932 | 0.88 | 8,591 | |
| 0.92 | -0.012 | -1.3% | 0.88 | 0.93 | 0.878 | 33,681 | |
| 0.932 | +0.004 | +0.4% | 0.928 | 0.954 | 0.878 | 100,827 | |
| 0.928 | +0.008 | +0.9% | 0.948 | 0.948 | 0.86 | 34,051 | |
| 0.92 | +0.02 | +2.2% | 0.90 | 0.922 | 0.85 | 33,615 | |
| 0.90 | +0.002 | +0.2% | 0.90 | 0.966 | 0.852 | 70,516 | |
| 0.898 | -0.066 | -6.8% | 0.958 | 0.982 | 0.88 | 77,556 | |
| 0.964 | +0.048 | +5.2% | 0.882 | 0.966 | 0.882 | 159,864 | |
| 0.916 | -0.068 | -6.9% | 0.836 | 0.956 | 0.836 | 83,659 | |
| 0.984 | +0.074 | +8.1% | 0.898 | 1.06 | 0.75 | 323,688 | |
| 0.91 | +0.01 | +1.1% | 0.902 | 0.922 | 0.90 | 21,759 | |
| 0.90 | -0.038 | -4.1% | 0.928 | 0.928 | 0.882 | 93,437 | |
| 0.938 | -0.01 | -1.1% | 0.948 | 0.948 | 0.878 | 14,267 | |
| 0.948 | +0.026 | +2.8% | 0.906 | 0.95 | 0.906 | 66,724 | |
| 0.922 | +0.02 | +2.2% | 0.954 | 0.97 | 0.904 | 26,184 | |
| 0.902 | -0.038 | -4.0% | 0.94 | 0.956 | 0.902 | 61,097 | |
| 0.94 | -0.004 | -0.4% | 0.948 | 0.954 | 0.92 | 90,292 | |
| 0.944 | -0.008 | -0.8% | 0.952 | 0.952 | 0.93 | 77,800 | |
| 0.952 | -0.028 | -2.9% | 0.98 | 0.98 | 0.95 | 63,806 | |
| 0.98 | -0.01 | -1.0% | 0.984 | 0.996 | 0.952 | 50,922 | |
| 0.99 | +0.04 | +4.2% | 0.996 | 1.05 | 0.952 | 140,845 | |
| 0.95 | -0.07 | -6.9% | 1.05 | 1.125 | 0.89 | 293,923 |
Splits
2 splits since 2020 · OMXCOP:STENO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1.0594-for-1 | Split | |
| 1.1131-for-1 | Split |
- Ticker
- Munich:S7C
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Aug 20, 2026
STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
Latest news
STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
Aug 20, 2026
Closed 0.95 (-6.9%) on Aug 20, 2026
STENOCARE completes integration of CannGros ApS
Jul 3, 2026
Closed 1.03 (+1.0%) on Jul 6, 2026
Notice to Annual General Meeting in STENOCARE A/S
Apr 7, 2026
Closed 1.04 (+1.0%) on Apr 8, 2026
STENOCARE A/S publishes Annual Report 2025
Mar 26, 2026
Closed 1.21 (+50.2%) on Mar 26, 2026
Interim report fourth quarter and Financial Statement Release 2025
Feb 26, 2026
Closed 1.42 (+3.3%) on Feb 26, 2026
STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership
Feb 11, 2026
Closed 1.54 (+6.9%) on Feb 11, 2026
Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany
Jan 27, 2026
Closed 1.49 (+2.4%) on Jan 28, 2026
Trading in STENOCARE shares by closely related party to board member
Dec 30, 2025
Closed 1.48 (-3.6%) on Dec 30, 2025
Stenocare acquires Canngros
Nov 21, 2025
Closed 1.75 (-5.4%) on Nov 21, 2025
StenoCare A/S on 6ix
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- News releases
- 8 in the last 12 months · 18 in all · newest Aug 20, 2026 · oldest 2025
Where StenoCare A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Copenhagen:STENO · Home listing | Copenhagen | Denmark | DKK |
| Frankfurt:S7C | Frankfurt | Germany | EUR |
| Munich:S7C · This page | Munich | Germany | EUR |
Valuation
EV/sales 2.0× against a median of 1.6×: 6th lowest of 11 Tobacco & cannabis companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 25.63M DKK
- P/E
- Loss
- EV/sales
- 2.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.2×
- Gross margin
- 18.0%
- Operating margin
- −10.5%
- Net margin
- −13.9%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Tobacco & cannabis: the 10 companies nearest in size, of 97 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| StenoCare A/S · OMXCOP:STENO | US$3.74M | US$3.76M | n/a | 2.0× | n/a | 3.2× | −13.9% | 0.1× | n/a |
| PharmaCielo Ltd. · TSXV:PCLO | US$5.39M | US$5.34M | n/a | 2.1× | n/a | n/a | −103.1% | n/a | -0.16 |
| Ecs Botanics Holdings Ltd · ASX:ECS | US$5.32M | US$8.44M | n/a | 0.6× | n/a | 0.3× | −9.1% | 0.3× | n/a |
| Avant Brands Inc · TSX:AVNT | US$5.13M | US$12.54M | n/a | 0.5× | n/a | 0.3× | −24.7% | 0.6× | 0.35 |
| Zelira Therapeutics Ltd. · ASX:ZLD | US$4.35M | US$5.76M | n/a | 13,283× | n/a | n/a | n/a | n/a | n/a |
| Enorama Pharma AB · OMXSTO:ERMA | US$4.29M | US$4.08M | n/a | 28.8× | n/a | n/a | n/a | n/a | n/a |
| Blueberries Medical Corp. · CSE:BBM | US$4.04M | US$4.03M | n/a | 20.8× | n/a | 202× | −384.3% | 0.0× | -0.18 |
| cbdMD, Inc. · AMEX:YCBD | US$4.03M | US$1.92M | n/a | 0.1× | n/a | 0.5× | −13.8% | 0.0× | 1.10 |
| Mercanto Holdings Inc · TSXV:MUSH | US$3.96M | US$3.59M | n/a | 1.1× | 87.6× | 11.5× | −0.1% | 0.0× | -0.47 |
| Christina Lake Cannabis Corp · CSE:CLC | US$3.46M | US$4.63M | n/a | 0.5× | n/a | 0.5× | −30.4% | 0.4× | 0.91 |
| Nicoccino Holding AB · OMXSTO:NICO | US$3.02M | US$2.88M | n/a | 35.3× | n/a | 21.9× | n/a | 0.5× | n/a |
| Median of the others | US$4.17M | US$4.36M | 1.6× | 87.6× | 0.5× | −24.7% | 0.3× | 0.09 |
Team and board
Officers
| Officer | Role |
|---|---|
| Thomas Skovlund Schnegelsberg | CEO |
| Peter Bugge Johansen | CFO |
| Rolf Steno Petersen | CCO and Co-Founder |
Board
| Director | Role |
|---|---|
| Marianne Wier | Non-executive Chairman of the Board of Directors |
| Henrik Elbæk Pedersen | Non-executive member of the Board of Directors |
| Jeppe Bo Petersen | Non-executive member of the Board of Directors |
| Rolf Steno Petersen | CCO and Co-Founder |
| Søren Melsing Frederiksen | Non-executive member of the Board of Directors |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2021 | May 6, 2021 | −6.8% |
Financials
Annual, in DKK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.02M | 2.23M | 3.76M | 4.49M | 1.57M | 198.4K | 8.78M | 4.14M |
| Cost of revenue | 8.83M | 20.7M | 10.2M | 10.9M | 15.7M | 12.3M | 11.4M | 7.74M |
| Gross profit | -1.81M | -18.5M | -6.42M | -6.41M | -14.1M | -12.1M | -2.63M | -3.59M |
| Selling, general and administrative | 7.41M | 5.27M | ||||||
| Operating income | -1.77M | -33.1M | -15.9M | -16.5M | -14.0M | -12.0M | 4.37M | -3.59M |
| Depreciation and amortization | 69.8K | 8.86M | 3.38M | 3.31M | 1.09M | 240.6K | 58.9K | 1.40K |
| EBITDA | -1.70M | -24.2M | -12.6M | -13.2M | -13.0M | -11.8M | 4.43M | -3.59M |
| Interest expense | 658.3K | 1.54M | 2.88M | 1.29M | 213.2K | 1.68M | 2.12M | 12.6K |
| Income before tax | -2.39M | -34.6M | -18.8M | -17.9M | -14.3M | -13.7M | 2.25M | -3.61M |
| Income tax | -108.3K | -1.25M | -1.58M | -1.53M | -1.93M | 544.0K | -328.7K | |
| Net income | -2.39M | -34.5M | -17.6M | -16.3M | -12.7M | -11.8M | 1.70M | -3.28M |
| Earnings per share, basic | -0.06 | -1.00 | -1.26 | -1.35 | -1.05 | -1.06 | 0.17 | -0.33 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 787.4K | 1.38M | 9.50M | 4.43M | 11.7M | 26.4M | 21.7M | 18.1M |
| Short-term investments | -488.4K | |||||||
| Receivables | 3.00M | 1.80M | 3.92M | 4.70M | 1.84M | 599.0K | 637.8K | 3.05M |
| Inventory | 307.0K | 319.6K | 45.6K | 727.9K | 18.4K | 0 | 0 | 84.2K |
| Current assets | 4.71M | 5.26M | 14.9M | 13.1M | 15.1M | 29.2M | 22.8M | 21.7M |
| Property, plant and equipment | 26.0M | 28.4M | 26.7M | 626.8K | 19.6K | |||
| Goodwill | 7.58M | |||||||
| Total assets | 12.6M | 19.7M | 38.1M | 39.6M | 43.9M | 56.3M | 31.6M | 21.7M |
| Accounts payable | 410.3K | 1.81M | 1.48M | 2.51M | 1.19M | 1.44M | 816.3K | 602.9K |
| Current liabilities | 3.17M | 7.49M | 11.4M | 9.61M | 2.71M | 3.69M | 18.1M | 1.24M |
| Long-term debt | 0 | 1.97M | 0 | 3.53M | 0 | |||
| Total debt | 1.99M | 3.73M | 9.68M | 11.3M | 1.24M | 80.0K | 16.6M | |
| Total liabilities | 3.17M | 23.2M | 12.3M | 15.5M | 3.69M | 3.77M | 18.1M | 1.24M |
| Shareholders' equity | 9.47M | -3.47M | 25.8M | 24.1M | 40.2M | 52.6M | 13.5M | 20.5M |
| Shares outstanding | 43.2M | 34.5M | 13.9M | 12.1M | 12.1M | 11.1M | 10.1M | 10.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -7.21M | -7.14M | -10.0M | -15.0M | -13.3M | -12.7M | -2.54M | -5.57M |
| Capital spending | -4 | -44.4K | -176.4K | -935.9K | -3.27M | -18.5M | -8.39M | -21.0K |
| Free cash flow | -7.21M | -7.19M | -10.2M | -16.0M | -16.6M | -31.2M | -10.9M | -5.60M |
| Cash from investing | -364.6K | -28.2K | -176.6K | -936.8K | -2.54M | -18.5M | -8.88M | -27.0K |
| Cash from financing | 6.98M | -948.5K | 15.3M | 8.68M | 1.24M | 35.9M | 15.0M | 23.7M |
| Change in cash | -593.2K | -8.12M | 5.07M | -7.29M | -14.6M | 4.63M | 3.58M | 18.1M |
Cap table
Built by 6ix from StenoCare A/S’ releases
- Common shares
- 43,195,978
- Fully diluted
- 43,195,978
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 43,195,978 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 43,195,978 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Henrik Elbæk Pedersen | Non-executive member of the Board of Directors · Since at least Apr 7, 2026 |
| Jeppe Bo Petersen | Non-executive member of the Board of Directors · Since at least Apr 7, 2026 |
| Marianne Wier | Non-executive Chairman of the Board of Directors · Since at least Apr 7, 2026 |
| Peter Bugge Johansen | CFO · Since at least Mar 26, 2026 |
| Rolf Steno Petersen | CCO and Co-Founder · Since at least Apr 7, 2026 |
| Søren Melsing Frederiksen | Non-executive member of the Board of Directors · Since at least Apr 7, 2026 |
| Thomas Skovlund Schnegelsberg | CEO · Since at least Aug 20, 2026 |
| Ulrik Bayer | chairman of the meeting · May 15, 2025 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about StenoCare A/S.